Clinical Benefit of Islet Xenotransplantation for the Treatment of Type 1 Diabetes

Background: Allogeneic islet transplantation has become a viable option for the treatment of unstable type 1 diabetes. However, the donor shortage and the necessity of the immunosuppressive drugs are two major issues. To solve these issues, we performed islet xenotransplantation using encapsulated n...

Full description

Bibliographic Details
Main Authors: Shinichi Matsumoto, MD, Adrian Abalovich, MD, Carlos Wechsler, MD, Shaun Wynyard, PhD, Robert B. Elliott, MD
Format: Article
Language:English
Published: Elsevier 2016-10-01
Series:EBioMedicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396416303899